MUMBAI, India, Aug. 10 -- Intellectual Property India has published a patent application (202421069464 A) filed by Cipla Limited on September 13, 2024, for Ophthalmic Composition Of Dexamethasone.
Inventors include Bhadauria, Pradeep; Kaliaperumal, Arunprasath; Chitre, Trupti; Marathe, Vinayak; and Narkhede, Rahul.
The application for the patent was published on July 31, 2026, under issue no. 31/2026.
Abstract: The present invention discloses an ophthalmic composition comprising dexamethasone or its pharmaceutically acceptable salt thereof and that is used to treat cataract surgery pain and diabetic macular edema. The present invention relates to use of a topically administrable ophthalmic suspension composition of dexamethasone, or it pharmaceutically acceptable salt thereof suspended in pharmaceutically acceptable vehicle, wherein the pharmaceutical acceptable vehicle comprises at least one excipient selected from suspending agent, tonicity agent, antimicrobial agent, buffering agent, chelating agent, antioxidant, surface active agent, and pH adjusting agent.
Disclaimer: Curated by HT Syndication.
